medical oncology

Summary

Summary: A subspecialty of internal medicine concerned with the study of neoplasms.

Top Publications

  1. pmc Enhancing communication between oncologists and patients with a computer-based training program: a randomized trial
    James A Tulsky
    Duke University, Veterans Affairs Medical Center, Durham, North Carolina, USA
    Ann Intern Med 155:593-601. 2011
  2. pmc Genetic assessment of breast cancer risk in primary care practice
    Wylie Burke
    Department of Bioethics and Humanities, University of Washington, Seattle, Washington 98195 7120, USA
    Am J Med Genet A 149:349-56. 2009
  3. pmc Analysis of the yield of phase II combination therapy trials in medical oncology
    Michael L Maitland
    Section of Hematology Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA
    Clin Cancer Res 16:5296-302. 2010
  4. ncbi Improving patient emotional functioning and psychological morbidity: evaluation of a consultation skills training program for oncologists
    Afaf Girgis
    Centre for Health Research and Psycho oncology, The Cancer Council NSW, University of Newcastle and Hunter Medical Research Institute, Room 230A, Level 2 David Maddison Building, Callaghan, NSW 2308, Australia
    Patient Educ Couns 77:456-62. 2009
  5. pmc Young patients', parents', and survivors' communication preferences in paediatric oncology: results of online focus groups
    Marieke Zwaanswijk
    NIVEL, Netherlands Institute for Health Services Research, P, O, Box 1568, 3500 BN Utrecht, The Netherlands
    BMC Pediatr 7:35. 2007
  6. ncbi Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
    Donald Poon
    National Cancer Centre, Singapore Duke NUS Graduate Medical School, Singapore
    Lancet Oncol 10:1111-8. 2009
  7. ncbi Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology
    Ultan McDermott
    Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center, Charlestown, MA 02129, USA
    J Clin Oncol 27:5650-9. 2009
  8. pmc Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
    Oliver A Cornely
    Klinikum der Universität zu Köln, Klinik I für Innere Medizin Zentrum für Klinische Studien BMBF 01KN0706, Koln, Germany
    Haematologica 94:113-22. 2009
  9. pmc The meaning and measurement of implementation climate
    Bryan J Weiner
    Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, North Carolina, USA
    Implement Sci 6:78. 2011
  10. ncbi Increasing oncologists' skills in eliciting and responding to emotional cues: evaluation of a communication skills training program
    Phyllis Butow
    Medical Psychology Research Unit, School of Psychology, Brenan McCallum Building, A18, University of Sydney, Camperdown, NSW 2006, Australia
    Psychooncology 17:209-18. 2008

Detail Information

Publications339 found, 100 shown here

  1. pmc Enhancing communication between oncologists and patients with a computer-based training program: a randomized trial
    James A Tulsky
    Duke University, Veterans Affairs Medical Center, Durham, North Carolina, USA
    Ann Intern Med 155:593-601. 2011
    ..Quality cancer care requires addressing patients' emotions, which oncologists infrequently do. Multiday courses can teach oncologists skills to handle emotion; however, such workshops are long and costly...
  2. pmc Genetic assessment of breast cancer risk in primary care practice
    Wylie Burke
    Department of Bioethics and Humanities, University of Washington, Seattle, Washington 98195 7120, USA
    Am J Med Genet A 149:349-56. 2009
    ..Educational efforts may be most successful when they emphasize the value of genetic counseling for individuals at risk for inherited cancer and the connection between genetic risk and specific prevention measures...
  3. pmc Analysis of the yield of phase II combination therapy trials in medical oncology
    Michael L Maitland
    Section of Hematology Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA
    Clin Cancer Res 16:5296-302. 2010
    ..We hypothesized that recognized flaws of single-arm trials could be magnified in combination treatment studies, leading to many reported positive phase II trials but with a low fraction resulting in practice-changing phase III trials...
  4. ncbi Improving patient emotional functioning and psychological morbidity: evaluation of a consultation skills training program for oncologists
    Afaf Girgis
    Centre for Health Research and Psycho oncology, The Cancer Council NSW, University of Newcastle and Hunter Medical Research Institute, Room 230A, Level 2 David Maddison Building, Callaghan, NSW 2308, Australia
    Patient Educ Couns 77:456-62. 2009
    ....
  5. pmc Young patients', parents', and survivors' communication preferences in paediatric oncology: results of online focus groups
    Marieke Zwaanswijk
    NIVEL, Netherlands Institute for Health Services Research, P, O, Box 1568, 3500 BN Utrecht, The Netherlands
    BMC Pediatr 7:35. 2007
    ..It is not clear to what extent this mirrors patients' and parents' preferences. This study investigated communication preferences of childhood cancer patients, parents, and survivors of childhood cancer...
  6. ncbi Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
    Donald Poon
    National Cancer Centre, Singapore Duke NUS Graduate Medical School, Singapore
    Lancet Oncol 10:1111-8. 2009
    ....
  7. ncbi Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology
    Ultan McDermott
    Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center, Charlestown, MA 02129, USA
    J Clin Oncol 27:5650-9. 2009
    ..In this review, we summarize recent developments in this area, and we highlight some of the logistical challenges posed by this emerging paradigm in medical oncology.
  8. pmc Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
    Oliver A Cornely
    Klinikum der Universität zu Köln, Klinik I für Innere Medizin Zentrum für Klinische Studien BMBF 01KN0706, Koln, Germany
    Haematologica 94:113-22. 2009
    ..Fluconazole 400 mg/d is recommended in allogeneic stem cell recipients until development of graft versus host disease only (Level A I). Aerosolized liposomal amphotericin B is recommended during prolonged neutropenia (Level B II)...
  9. pmc The meaning and measurement of implementation climate
    Bryan J Weiner
    Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, North Carolina, USA
    Implement Sci 6:78. 2011
    ..In this article, we clarify the meaning of implementation climate, discuss several measurement issues, and propose guidelines for empirical study...
  10. ncbi Increasing oncologists' skills in eliciting and responding to emotional cues: evaluation of a communication skills training program
    Phyllis Butow
    Medical Psychology Research Unit, School of Psychology, Brenan McCallum Building, A18, University of Sydney, Camperdown, NSW 2006, Australia
    Psychooncology 17:209-18. 2008
    ..Psychological morbidity in cancer patients is common, but often undetected and untreated. We developed a communication skills training (CST) program targeting this issue, and evaluated its impact on doctor behaviour...
  11. ncbi The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)
    P G Casali
    Ann Oncol 18:1923-5. 2007
  12. pmc The quality of web-based oncology guidelines and protocols: how do international sites stack up?
    J M Langton
    Lowy Cancer Research Centre, Adult Cancer Program, Prince of Wales Clinical School, The University of New South Wales, Sydney, New South Wales, 2052, Australia
    Br J Cancer 105:1166-72. 2011
    ..Despite the widespread use of web-based guidelines and protocols, the quality of these resources has not been evaluated. This study addresses this gap...
  13. ncbi Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Florian Weissinger
    Klinik fur Innere Medizin, Hämatologie Onkologie und Palliativmedizin, Evangelisches Krankenhaus Bielefeld, Schildescher Str 99, 33611 Bielefeld, Germany
    Ann Hematol 91:1161-74. 2012
    ..In this review we discuss all aspects of infections after autologous stem transplantation, including epidemiology, diagnostics, therapeutic algorithms, prophylaxis and supportive therapy...
  14. ncbi [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors
    O Schillaci
    Department of Biopathology and Diagnostic Imaging, University of Rome Tor Vergata, Rome, Italy
    Q J Nucl Med Mol Imaging 49:133-44. 2005
    ..The possible role of integrated dual-modality images using SPET with SM or TF is also briefly discussed...
  15. pmc Distribution and determinants of patient satisfaction in oncology with a focus on health related quality of life
    Christopher G Lis
    Cancer Treatment Centers of America at Midwestern Regional Medical Center, 2610 Sheridan Road, Zion, IL 60099, USA
    BMC Health Serv Res 9:190. 2009
    ..We investigated the clinical, demographic and QoL factors associated with patient satisfaction in a large heterogeneous sample of cancer patients...
  16. ncbi Cancer care, money, and the value of life: whose justice? Which rationality?
    Daniel P Sulmasy
    The John J Conley Department of Ethics, St Vincent s Hospital Manhattan and New York Medical College, New York, NY 10011, USA
    J Clin Oncol 25:217-22. 2007
    ..Oncologists would then be free to advocate for their patients within the constraints imposed by this public process...
  17. ncbi How to implement the multidisciplinary approach in prostate cancer management: the Belgian model
    Simon Van Belle
    Department of Medical Oncology, University Hospital Ghent, Ghent, Belgium
    BJU Int 101:2-4. 2008
    ....
  18. ncbi Educating undergraduate medical students about oncology: a literature review
    Judith Gaffan
    Academic Centre for Medical Education, Royal Free and University College Medical School Archway Campus, London, United Kingdom
    J Clin Oncol 24:1932-9. 2006
    ..This article is a review of the literature regarding teaching oncology to undergraduate medical students...
  19. ncbi Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study
    Ria Blaauwbroek
    Department of Paediatrics, Division of Paediatric Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands
    Lancet Oncol 9:232-8. 2008
    ....
  20. ncbi Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology
    Nicholas J Vogelzang
    American Society of Clinical Oncology, 2318 Mill Rd, Suite 800, Alexandria, VA 22314, USA
    J Clin Oncol 30:88-109. 2012
    ..We now have a tremendous opportunity to use today's knowledge and collaborate across all facets of cancer care to conquer this deadly disease. Michael P. Link, MD President American Society of Clinical Oncology...
  21. ncbi Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review
    Julien Peron
    Service d Oncologie Medicale, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165 Chemin du Grand Revoyet, Pierre Benite, France
    J Natl Cancer Inst 104:982-9. 2012
    ..However, there is little information regarding the adherence to CONSORT guidelines of recent publications of randomized controlled trials (RCTs) in oncology...
  22. ncbi Identifying an accurate pre-screening tool in geriatric oncology
    Eliane Kellen
    Leuven Centre of Cancer Prevention, University Hospitals Leuven, Belgium
    Crit Rev Oncol Hematol 75:243-8. 2010
    ..14% had two or more impairments of the CGA or were cognitively impaired. The physical and disability questions are useful, but all other screening instruments miss too many cases...
  23. ncbi Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey
    Deborah Schrag
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 25:233-7. 2007
    ..As chemotherapy costs escalate, financial concerns have become relevant for more cancer patients. Yet, little is known about how oncologists communicate with patients about coping with chemotherapy treatment costs...
  24. ncbi What is the evidence for the use of mindfulness-based interventions in cancer care? A review
    Christina Shennan
    Cancer Help Ltd, Croston House, Garstang, Lancashire, UK
    Psychooncology 20:681-97. 2011
    ..The aim of this paper is to present and critically appraise the evidence for the use of mindfulness-based interventions in cancer care...
  25. ncbi Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)
    Pilar Garrido
    Medical Oncology Service, Universitary Hospital Ramon y Cajal, Madrid, Spain
    Clin Transl Oncol 14:338-49. 2012
    ..This consensus statement was conceived as a joint initiative of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP), and makes diagnostic and treatment recommendations for ..
  26. pmc A multimarker prognostic assay for primary cutaneous melanoma
    Mohammed Kashani-Sabet
    Auerback Melanoma Research Laboratory and Melanoma Center, Comprehensive Cancer Center, and Departments of Pathology, Surgery, and Urology, University of California San Francisco, San Francisco, California, USA
    Clin Cancer Res 15:6987-92. 2009
    ..To determine the prognostic significance of a multimarker assay incorporating expression levels of three molecular markers in primary cutaneous melanoma...
  27. ncbi Cost of cancer care: issues and implications
    Neal J Meropol
    Division of Medical Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    J Clin Oncol 25:180-6. 2007
    ..Our overall goal is to frame debate about health policy concerns that influence the clinical practice of oncology...
  28. ncbi Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review
    Andreas du Bois
    Department of Gynecology and Gynecologic Oncology, Dr Horst Schmidt Klinik HSK, Ludwig Erhard Str 100, D 65199 Wiesbaden, Germany
    Gynecol Oncol 112:422-36. 2009
    ..This systematic review summarizes the available data evaluating the impact of different physician and hospital characteristics on outcome in ovarian cancer patients...
  29. ncbi Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009
    F Stiefel
    Psychiatry Service, Department of Psychiatry, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland
    Ann Oncol 21:204-7. 2010
    ..While these trainings have been demonstrated to be effective, there is an important heterogeneity with regard to implementation and with regard to evidence of different aspects of CST...
  30. ncbi Recommendations on the use of 18F-FDG PET in oncology
    James W Fletcher
    Department of Radiology, Indiana Purdue University, Indiana University School of Medicine, Indianapolis, Indiana 46202 5253, USA
    J Nucl Med 49:480-508. 2008
    ..Outcomes of interest included the use of (18)F-FDG PET for diagnosing, staging, and detecting the recurrence or progression of cancer...
  31. ncbi Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care
    B E Hillner
    Massey Cancer Center and Department of Internal Medicine, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298 0170, USA
    J Clin Oncol 18:2327-40. 2000
    ..To conduct a comprehensive review of the health services literature to search for evidence that hospital or physician volume or specialty affects the outcome of cancer care...
  32. ncbi Diagnosis disclosure in a Portuguese oncological centre
    J Ferraz Gonçalves
    Unidade de Cuidados Continuados, Instituto Portugues de Oncologia, Porto, Portugal
    Palliat Med 15:35-41. 2001
    ..This subject is a very important topic of research both in Portugal and in other countries, as many published recommendations are not research based...
  33. ncbi Mapping the emergence and development of translational cancer research
    Alberto Cambrosio
    Department of Social Studies of Medicine, McGill University, Montreal, QC, Canada
    Eur J Cancer 42:3140-8. 2006
    ....
  34. ncbi Doctor-patient communication and satisfaction with care in oncology
    Anne Bredart
    Inter Disciplinary Supportive Care Department for the Oncology Patient, Institut Curie, Paris, France
    Curr Opin Oncol 17:351-4. 2005
    ..This review summarises current knowledge on the impact on patient satisfaction of initiatives undertaken to enhance the communication between doctors and their patients in oncology...
  35. ncbi A randomized study assessing the efficacy of communication skill training on patients' psychologic distress and coping: nurses' communication with patients just after being diagnosed with cancer
    Sakiko Fukui
    School of Nursing, Chiba University, Chiba, Japan
    Cancer 113:1462-70. 2008
    ..This study aimed to assess the efficacy of CST for nurses in improving psychologic distress and coping among patients after being informed of a cancer diagnosis...
  36. ncbi Oncologists' attitudes toward and practices in giving bad news: an exploratory study
    Walter F Baile
    University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 20:2189-96. 2002
    ..To examine the attitudes and practices of oncologists in disclosure of unfavorable medical information to cancer patients...
  37. ncbi Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 47:1229-36. 2009
    ..Recent healthcare system and environmental changes may have reduced treatment gaps...
  38. ncbi Impact of the media and the internet on oncology: survey of cancer patients and oncologists in Canada
    X Chen
    Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    J Clin Oncol 19:4291-7. 2001
    ..Strategic efforts are needed to improve the quality of medical news reporting by the media, and to provide guidance for patients to understand their disease and interpret such information better...
  39. ncbi Evidence-based recommendations for information and care planning in cancer care
    Anne Walling
    David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    J Clin Oncol 26:3896-902. 2008
    ..The standards presented here for information and care planning in cancer care should be incorporated into care pathways and should become the expectation rather than the exception...
  40. ncbi Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays
    Julia D Wulfkuhle
    Center for Applied Proteomics Molecular Medicine, George Mason University, Manassas, VA, USA
    Nat Clin Pract Oncol 3:256-68. 2006
    ....
  41. pmc Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis
    Jie Feng Cui
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China
    World J Gastroenterol 14:1257-62. 2008
    ....
  42. ncbi Physician referral for fertility preservation in oncology patients: a national study of practice behaviors
    Gwendolyn P Quinn
    H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    J Clin Oncol 27:5952-7. 2009
    ..This study examined the referral practices of oncologists in the United States...
  43. ncbi Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology
    Henry M Kuerer
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Ann Surg Oncol 14:3043-53. 2007
    ..Studies show that 30-50% of medical oncologists experience burnout, but little is known about burnout among surgical oncologists. We hypothesized that wide variation in burnout and career satisfaction exist among surgical oncologists...
  44. ncbi Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance
    Hideyuki Akaza
    Department of Urology, University of Tsukuba, Tsukuba, Ibaraki, Japan
    Jpn J Clin Oncol 34:329-36. 2004
    ..Hormone therapy for prostate cancer has empirically prevailed in Japan. We planned to evaluate the trends and outcome of hormone therapy for establishing an adequate guideline...
  45. ncbi ACCO: ASCO core curriculum outline
    Hyman B Muss
    Education, Science and Career Development, American Society of Clinical Oncology, 1900 Duke Street, Suite 200, Alexandria, VA 22314, USA
    J Clin Oncol 23:2049-77. 2005
  46. ncbi A new informed consent form model for cancer patients: preliminary results of a prospective study by the Italian Association of Medical Oncology (AIOM)
    Stefania Gori
    Medical Oncology, Perugia Hospital, Via Dottori 1, 06122 Perugia, Italy
    Patient Educ Couns 87:243-9. 2012
    ....
  47. ncbi Monoclonal antibodies for medical oncology: a few critical perspectives
    Cristobal Belda-Iniesta
    Biomarkers and Experimental Therapeutics Group, IdiPAZ, University Hospital La Paz, Madrid, Spain
    Clin Transl Oncol 13:84-7. 2011
    ..This review aims to discuss a few imminent indications of current mAbs that are used for solid tumours and to briefly introduce future mAbs to the reader...
  48. pmc Factors associated with the career choices of hematology and medical oncology fellows trained at academic institutions in the United States
    Leora Horn
    Vanderbilt Ingram Cancer Center, Nashville, TN, USA
    J Clin Oncol 29:3932-8. 2011
    ....
  49. ncbi [Multidisciplinary team meetings in cancerology: setting priorities for improvement]
    Pascale Guillem
    CHU de Grenoble, centre de coordination en cancérologie, France
    Bull Cancer 98:989-98. 2011
    ..Leading to completeness raises questions about medical time employment and meaning of the MDT meeting for standard clinical cases. The priority seems to enforce multidisciplinarity rather than reach completeness...
  50. ncbi Do oncologists believe new cancer drugs offer good value?
    Eric Nadler
    Dana Faber Cancer Institute Harvard Medical School, Boston, MA, USA
    Oncologist 11:90-5. 2006
    ..Oncologists play a pivotal role in treatment decisions, yet it is unclear whether they perceive high-cost new treatments to offer good value or how therapeutic costs factor into their treatment recommendations...
  51. ncbi Communicating sad, bad, and difficult news in medicine
    Lesley Fallowfield
    Cancer Research UK Psychosocial Oncology Group, Brighton and Sussex Medical School, University of Sussex, BN1 9QG, Falmer, UK
    Lancet 363:312-9. 2004
    ..We focus mainly on difficulties encountered involving parents in an obstetric or paediatric setting, people in acute trauma situations such as accident and emergency departments, and patients with cancer...
  52. ncbi Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma
    Carlos Gómez-Martín
    GI Cancer Research Unit, Clinical Research Programme, National Cancer Research Centre, C Melchor Fernandez Almagro 3, Madrid, Spain
    Clin Transl Oncol 13:636-51. 2011
    ..Any laboratories which do not meet the minimum standards set out in the guidelines must make every effort to achieve compliance...
  53. pmc Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer
    Michael J Fisch
    The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    J Clin Oncol 30:1980-8. 2012
    ..Pain is prevalent among patients with cancer, yet pain management patterns in outpatient oncology are poorly understood...
  54. ncbi Comparison of recommendations for radiotherapy from two contemporaneous thoracic multidisciplinary meeting formats: co-located and video conference
    G Stevens
    Department of Radiation Oncology, Auckland Hospital, Auckland, New Zealand
    Intern Med J 42:1213-8. 2012
    ..In the Auckland/Northland region, there are two contemporaneous weekly TMDM using different formats; one is a co-located TMDM (C-TMDM), and the other is a video conference TMDM (V-TMDM) connecting different locations...
  55. ncbi Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology
    Antonio Marchetti
    Center of Predictive Molecular Medicine, Center of Excellence on Aging, University Foundation, Chieti, Italy
    J Thorac Oncol 8:352-8. 2013
    ..The European Medicines Agency accepted the regulatory submission of crizotinib for the treatment of these patients. Therefore, ALK gene testing has become mandatory to choose the most appropriate therapy...
  56. pmc American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment
    ROBIN T ZON
    Michiana Hematology Oncology, South Bend, IN, USA
    J Clin Oncol 27:986-93. 2009
    ....
  57. ncbi Integration of geriatrics in oncology training--the relationship between the academic center and the community
    S M Lichtman
    Department of Medicine, North Shore University Hospital, New York University School of Medicine, Manhasset 11030, USA
    Crit Rev Oncol Hematol 33:57-9. 2000
    ..and the ensuing large increase in the number of older cancer patients require that the subspeciality of Medical Oncology respond quickly and effectively to this need...
  58. ncbi Behind closed doors: systematic analysis of breast cancer consultation communication and predictors of satisfaction with communication
    Thomas F Hack
    Faculty of Nursing, University of Manitoba, Winnipeg, MB, Canada
    Psychooncology 19:626-36. 2010
    ....
  59. ncbi Does communication skills training make a difference to patients' experiences of consultations in oncology and palliative care services?
    L A Johnson
    Health Psychology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle, UK
    Eur J Cancer Care (Engl) 22:202-9. 2013
    ..Possible explanations for the findings are explored and implications for communication skills training are discussed...
  60. ncbi Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology
    P Lissoni
    Division of Radiation Oncology, Milan, Italy
    J Biol Regul Homeost Agents 20:29-35. 2006
    ....
  61. ncbi Breast cancer in Latin America: results of the Latin American and Caribbean Society of Medical Oncology/Breast Cancer Research Foundation expert survey
    Eduardo Cazap
    Latin American and Caribbean Society of Medical Oncology, Buenos Aires, Argentina
    Cancer 113:2359-65. 2008
    ..Alternative data collection strategies for understanding the state of breast cancer control programs in developing countries can help identify areas of improvement...
  62. ncbi Cancer patients' trust in their physician-a review
    Marij A Hillen
    Department of Medical Psychology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Psychooncology 20:227-41. 2011
    ..A review was undertaken of the current knowledge of the conceptualization, assessment, correlates, and consequences of cancer patients' trust in their physician...
  63. ncbi Measuring supportive care in medical oncology practice: lessons learned from the quality oncology practice initiative
    Kristen K McNiff
    American Society of Clinical Oncology, 2318 Mill Road, Suite 800, Alexandria, VA 22314, USA
    J Clin Oncol 26:3832-7. 2008
    We provide a brief review of the use of quality measures to assess supportive care in the medical oncology office...
  64. pmc The opinion of clinical staff regarding painfulness of procedures in pediatric hematology-oncology: an Italian survey
    Chiara Po'
    Pediatric Pain and Palliative Care Service, Department of Pediatrics, University of Padua, Italy
    Ital J Pediatr 37:27. 2011
    ..Aim of this study was to evaluate professionals' beliefs about painfulness of invasive procedures repeatedly performed in Pediatric Hemato-Oncology Units...
  65. ncbi Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs
    Scott R Berry
    Sunnybrook Odette Cancer Center, 2075 Bayview Ave, Toronto, Ontario, Canada
    J Clin Oncol 28:4149-53. 2010
    ..We compared their attitudes regarding the costs and cost-effectiveness of medications and related health policy...
  66. pmc Increasing access to medical oncology consultation in older patients with stage II-IIIA non-small-cell lung cancer
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Med Oncol 25:125-32. 2008
    ..Therefore it was managed by surgeons. However, with growing evidence of the benefit of adjuvant chemotherapy, such patients should also be evaluated by a medical oncologist...
  67. ncbi Quality assessment of a multidisciplinary tumour meeting for patients with head and neck cancer
    Joacim Stalfors
    Department of Otolaryngology, Head and Neck Surgery, Sahlgrenska University Hospital, Gothenbur, Sweden
    Acta Otolaryngol 127:82-7. 2007
    ..The mode of presentation of patients at the MDT meeting was not decisive for the quality of decisions regarding diagnosis and treatment plans...
  68. ncbi What should doctors know about cancer? Undergraduate medical education from a societal perspective
    Michael B Barton
    Collaboration for Cancer Outcomes Research and Evaluation, Liverpool Health Service, Liverpool, NSW, Australia
    Lancet Oncol 7:596-601. 2006
    ..Because assessment drives education, students' knowledge, skills, and attitudes relating to cancer should be assessed, and the outcomes of such assessment should inform the curriculum...
  69. ncbi Information sources used by New South Wales cancer clinicians: a qualitative study
    E L Tan
    Population Health and Use of Medicines Unit, St Vincent s Hospital, Sydney, NSW, Australia
    Intern Med J 36:711-7. 2006
    ..The work was carried out before activation of the Cancer Institute New South Wales Standard Cancer Treatment (CI-SCaT) programme...
  70. ncbi Lymphoma in elderly patients: novel functional assessment techniques provide better discrimination among patients than traditional performance status measures
    Abby B Siegel
    Departments of Medical Oncology and Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Clin Lymphoma Myeloma 7:65-9. 2006
    ....
  71. ncbi Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice
    Arti Hurria
    Division of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California 91010, USA
    J Am Geriatr Soc 55:1604-8. 2007
    ..To integrate the principles of geriatric assessment into the care of older patients with cancer in order to identify vulnerable older adults and develop interventions to optimize cancer treatment...
  72. pmc The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation
    William R Carpenter
    Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27516, USA
    Med Care 49:172-9. 2011
    ..This study examines whether organizational research affiliations and teaching affiliations are associated with accelerated diffusion of sentinel lymph node biopsy (SLNB), an innovation in the treatment of early-stage breast cancer...
  73. ncbi Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survery by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care
    Nathan I Cherny
    Medical Oncology and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel
    Cancer 98:2502-10. 2003
    In part of a quality improvement program, the European Society of Medical Oncology (ESMO) surveyed its membership regarding their involvement in and attitudes toward the palliative care (PC) of patients with advanced cancer.
  74. ncbi Analysis of oncology research from 2001 to 2010: a scientometric perspective
    Hongfang Shao
    School of Public Health, Department of Information Management, Shanxi Medical University, Taiyuan 030001, PR China
    Oncol Rep 29:1441-52. 2013
    ..These selected groups and individuals will carry out additional joint undertakings and solve complex problems encountered in oncology research...
  75. ncbi Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program
    Umberto Basso
    Division of Medical Oncology, Istituto Oncologico Veneto IOV IRCCS, Italy
    Crit Rev Oncol Hematol 66:163-70. 2008
    To evaluate management and outcome of patients >or=70 years admitted to our Medical Oncology ward and evaluated by Multidimensional Geriatric Assessment before treatment with standard or "elderly-friendly" chemotherapy regimens, a list ..
  76. ncbi Effects of weekly paclitaxel or paclitaxel plus carboplatin on functionality and symptoms of geriatric patients with cancer as measured by a brief geriatric oncology module: a pilot experience
    Cary A Presant
    California Cancer Medical Center, Los Angeles, California 91790, USA
    Cancer 103:2623-8. 2005
    ..To measure functionality, symptoms, and quality of life in elderly patients, a geriatric oncology module (GOM) was developed that could be rapidly and effectively administered in community oncology practices...
  77. ncbi Nanotechnology and tumor imaging: seizing an opportunity
    Daniel C Sullivan
    Division of Cancer Treatment and Diagnosis, National Cancer Institute, EPN Room 6052, 6130 Executive Boulevard, Rockville, MD 20892 7412, USA
    Mol Imaging 3:364-9. 2004
    ..Appropriately labeled and targeted nanoparticles could lead to a paradigm change in which cancer detection, diagnosis, and therapy are combined in a single molecular complex...
  78. ncbi We need a geriatric assessment for oncologists
    Arti Hurria
    Division of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA
    Nat Clin Pract Oncol 3:642-3. 2006
  79. ncbi Developing a multidisciplinary geriatric oncology program in a community cancer center
    Mary Pat Lynch
    The Joan Karnell Cancer Center, Pennsylvania Hospital in the University of Pennsylvania Health System, Philadelphia, USA
    Clin J Oncol Nurs 11:929-33. 2007
    ..It also describes a replicable plan for the development of a geriatric oncology program, which demonstrates how nursing can benefit from collaboration with other disciplines such as social work and psychology in service provision...
  80. ncbi Determinants of trust in the patient-oncologist relationship
    Nagashree Seetharamu
    New York University Medical Center, New York, New York, USA
    Palliat Support Care 5:405-9. 2007
    ..To enable the oncologist to better form a trusting relationship with the patient, this article describes four factors that influence patient trust...
  81. ncbi Implementing a web-based oncology protocol system in Australia: evaluation of the first 3 years of operation
    I M Hains
    Health Informatics Research and Evaluation Unit, Faculty of Health Sciences, The University of Sydney, Sydney, New South Wales, Australia
    Intern Med J 42:57-64. 2012
    ..eviq.org.au). We evaluated eviQ use at the point-of-care and determined the factors impacting on its uptake and routine use in the first three years of operation...
  82. ncbi eviQ cancer treatments online: how does the web-based protocol system fare in a comprehensive quality assessment?
    Julia M Langton
    Lowy Cancer Research Centre, Adult Cancer Program, Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia
    Asia Pac J Clin Oncol 7:357-63. 2011
    There have been few evaluations of the quality of computerized decision support tools in medical oncology despite their widespread use in clinical practice...
  83. ncbi Oncology treatment recommendations can be supported only by 1-2% of high-quality published evidence
    Sam Vincent
    Cancer Treat Rev 31:319-22. 2005
  84. pmc Follow-up care for cancer survivors: the views of clinicians
    D M Greenfield
    Academic Unit of Clinical Oncology, Weston Park Hospital, WhithamRoad, Sheffield S10 2SJ, UK
    Br J Cancer 101:568-74. 2009
    ..Evidence for the efficacy of late effects surveillance in adult cancer survivors is lacking and there is little agreement among clinicians on appropriate follow-up care...
  85. pmc Science, institutional archives and open access: an overview and a pilot survey on the Italian cancer research institutions
    Elisabetta Poltronieri
    Publishing Unit, Istituto Superiore di Sanita, Rome, Italy
    J Exp Clin Cancer Res 29:168. 2010
    ....
  86. ncbi Quality assurance in medical oncology within the EORTC. European Organisation for Research and Treatment of Cancer
    P Therasse
    EORTC Data Center, Av E Mounier, 83 11, 1200, Brussels, Belgium
    Eur J Cancer 38:S152-4. 2002
    ..by the European Commission enabled the QCC to address, amongst others, specific questions related to medical oncology. Both projects focused on the practices of chemotherapy delivery and the quality of data reporting...
  87. ncbi Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice
    Juan A Virizuela
    Medical Oncology Department, Hospital Virgen Macarena, Sevilla, Spain
    Clin Transl Oncol 14:499-504. 2012
    ..Also described is neuropathic pain and refractory pain, coadjuvant treatments and non pharmacological analgesic treatments. Finally, treatment of breakthrough pain is defined...
  88. ncbi Cancer prevention education in United States medical schools: how far have we come?
    Zeina Dajani
    Boston University School of Medicine, Boston, MA 02118, USA
    J Cancer Educ 23:204-8. 2008
    ..Herein, we review progress to date and call for a national forum of anti-cancer organizations to forge a new series of competencies for all US medical students...
  89. ncbi The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members
    Patricia A Ganz
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center at UCLA, University of California, Los Angeles UCLA School of Medicine, Los Angeles, CA 90095 6900, USA
    J Clin Oncol 24:2948-57. 2006
    ..In 2004, the American Society of Clinical Oncology (ASCO) Cancer Prevention Committee surveyed the members to describe involvement in clinical prevention activities...
  90. ncbi Communication skills training and clinicians' defenses in oncology: an exploratory, controlled study
    Mathieu Bernard
    Institute of Psychotherapy, University Hospital of Lausanne, Lausanne, Switzerland
    Psychooncology 19:209-15. 2010
    ..Defense mechanisms, defined as psychological processes protecting the individual against emotional stress, may be a mediating factor of skills improvement...
  91. ncbi A competency-based approach to expanding the cancer care workforce
    Alison P Smith
    C Change, Washington, DC, USA
    Medsurg Nurs 16:109-17; quiz 118. 2007
  92. ncbi Disclosure of prognosis to terminally ill patients: attitudes and practices among French physicians
    P Peretti-Watel
    Regional Center for Disease Control of South Eastern France, 23 rue Stanislas Torrents, 13006 Marseille, France
    J Palliat Med 8:280-90. 2005
    ..Disclosure of the prognosis to terminally ill patients is a strong prerequisite for integrating the physical, psychological, spiritual, and social aspects of end-of-life care...
  93. pmc Doctors' opinions on euthanasia, end of life care, and doctor-patient communication: telephone survey in France
    P Peretti-Watel
    Regional Center for Disease Control of South Eastern France, 13006 Marseille, France
    BMJ 327:595-6. 2003
  94. ncbi Factors associated with work stress and professional satisfaction in oncology staff
    Elizabeth Dougherty
    Department of Psychosocial Oncology and Palliative Care, Princess Margaret Hospital, University Health Network, Toronto, Canada
    Am J Hosp Palliat Care 26:105-11. 2009
    ..009), perceived lack of resources (odds ratio = 0.06; P = .007), and lack of control over the choice of workplace (odds ratio = 0.10; P = .03). Measures to address work-related stress should be included in the planning of cancer programs...
  95. ncbi [What's new in geriatric oncology?]
    Catherine Terret
    Programme d oncogériatrie, Centre Leon Berard, 28 rue Laennec, 69373 Lyon Cedex 08
    Bull Cancer 93:119-23. 2006
    ..This paper focuses on progress observed in the field of geriatric oncology both in France and worldwide...
  96. ncbi Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology
    Daniel A Hamstra
    Department of Radiation Oncology, The Center for Molecular Imaging, University of Michigan Medical Center, Ann Arbor, MI 48109 2200, USA
    J Clin Oncol 25:4104-9. 2007
    ..This review highlights the development of this technique and the state of current clinical understanding of its utility...
  97. ncbi Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer network
    Isabelle Ray-Coquard
    Centre Leon Berard, 28, rue Laennec, 69008 Lyon, France
    J Clin Oncol 23:4414-23. 2005
    ..In the present study, we evaluated the persistence of conformity to guidelines through a new medical audit...
  98. ncbi Knowledge and attitudes of Italian medical oncology residents toward the approach and treatment of pain
    Giampiero Porzio
    J Pain Symptom Manage 26:590-2. 2003
  99. ncbi Views of American oncologists about the purposes of clinical trials
    Steven Joffe
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Natl Cancer Inst 94:1847-53. 2002
    ..Many research subjects believe incorrectly that the primary purpose of clinical trials is to benefit the participants rather than to improve therapy for future patients. However, few data are available about how physicians view trials...
  100. ncbi American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays
    Deborah Schrag
    American Society of Clinical Oncology, Cancer Policy and Clinical Affairs, Alexandria, VA 22314, USA
    J Clin Oncol 22:3631-8. 2004
    ..To develop a technology assessment of chemotherapy sensitivity and resistance assays in order to define the role of these tests in routine oncology practice...
  101. ncbi Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial
    Lesley Fallowfield
    Cancer Research UK Psychosocial Oncology Group, School of Biological Science, University of Sussex, Brighton BN1 9QG, UK
    Lancet 359:650-6. 2002
    ..This study aimed to assess the efficacy of an intensive 3-day training course on communication skills in a randomised controlled trial with a two-by-two factorial design and several outcomes...

Research Grants73

  1. Overcoming Barriers to Early Phase Clinical Trials
    Bruce Chabner; Fiscal Year: 2004
    ..of low referral rates, we propose to establish a system for expediting referral of patients from community medical oncology practice at the Cambridge Hospital. Dr...
  2. Metabolic Syndrome and Breast Cancer: Effects of a Combined Exercise Intervention
    Christina Dieli-Conwright; Fiscal Year: 2013
    ..while participating in educational workshops and seminars within the Departments of Population Sciences, Medical Oncology, and Endocrinology at the City of Hope...
  3. IL-22 in epithelial regeneration after allogeneic transplant
    Alan Hanash; Fiscal Year: 2013
    ..The applicant, Dr. Alan Hanash, a medical oncology fellow at Memorial Sloan-Kettering Cancer Center (MSKCC) has outlined a five-year career plan that will build ..
  4. Inhibiting EGFR and ER pathways in NSCLC
    Edward B Garon; Fiscal Year: 2013
    ..2) Clinical- To become an academic leader in thoracic medical oncology, focused on patient-oriented research...
  5. Research and Mentoring on Energetic Factors and Cancer: Established Investigator
    Leslie Bernstein; Fiscal Year: 2013
    ..focus on mentoring junior faculty and postdoctoral fellows within the Departments of Population Sciences, Medical Oncology, and Surgical Oncology to encourage their pursuit of questions in cancer prevention and control...
  6. TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE
    DENNIS ROOP; Fiscal Year: 2013
    ..stages of skin SCCs, our clinical collaborators have recently established a new multidisciplinary Skin SCC Medical Oncology Program (SSMOP)...
  7. Nanotechnology for Multiplexed and Intraoperative Cancer Detection
    Shuming Nie; Fiscal Year: 2010
    ..with broad expertise cutting across nanotechnology, biocomputing, molecular imaging, oncologic surgery, and medical oncology. Designed for accelerated development and clinical impact within two years, the overall project will focus on ..
  8. The adoptive transfer of gene-modified T cells as a cell therapy for lymphoma
    MARCO L DAVILA; Fiscal Year: 2012
    ..applicant): The candidate for this NCI Career Development Award is Marco Davila, MD, PhD, who is currently a medical oncology fellow at Memorial Sloan-Kettering Cancer Center (MSKCC). Dr...
  9. State-of-the-Art PET/CT Instrumentation
    Richard E Carson; Fiscal Year: 2010
    ..support NIH-funded investigators in the Departments of Cardiology, Diagnostic Radiology, Internal Medicine, Medical Oncology, Obstetrics and Gynecology, and Therapeutic Radiology...
  10. 8th Annual Conference on Head and Neck Cancer
    Eben L Rosenthal; Fiscal Year: 2012
    ..of over 1500 attendees (2000 attendees in 2008) from four specialties representing the disciplines of medical oncology radiation oncology, radiology and head and neck surgery in order to ensure educational interaction within and ..
  11. Interventions Targeting Inflammation for Chemotherapy-Related Cognitive Problems
    MICHELLE C JANELSINS; Fiscal Year: 2013
    ..Jan Moynihan (immunology), Michelle Shayne (medical oncology), and Charles Heckler (biostatistics) provide specific expertise in key areas...
  12. Clinico-Genomic Assessment of Performance Status in Elderly AML Patients
    Arati V Rao; Fiscal Year: 2013
    ..completed a residency in Internal Medicine at Duke University followed by dual fellowship training in both Medical Oncology and Geriatrics at Duke University...
  13. ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
    Lori Rink; Fiscal Year: 2013
    ..members at FCCC and KUMC and internationally recognized experts in the field of translational research and medical oncology. I will have the opportunity to interact and discuss my research in regular meetings of working groups ..
  14. Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC)
    CORAL OGHENERUKEVWE OMENE; Fiscal Year: 2013
    ..had a long- standing commitment to translational, patient-oriented research and treatment in the field of medical oncology, as evidenced by my clinical and research training...
  15. State-of-the-Art Small Animal PET/CT Instrumentation
    Richard E Carson; Fiscal Year: 2013
    ..in the Departments of Biomedical Engineering, Cardiology, Diagnostic Radiology, Internal Medicine, Medical Oncology, Obstetrics and Gynecology, Neurology, Psychiatry, and Therapeutic Radiology...
  16. Mechanisms of tumor suppression by Fbw7
    Jonathan E Grim; Fiscal Year: 2010
    ..an independent research program that integrates basic studies of cancer biology with his training in medical oncology. The proposed research will provide broad-based training that will provide the applicant with the skills ..
  17. Training Program in Cancer Immunobiology
    Bradley W McIntyre; Fiscal Year: 2013
    ..Biology (1), Biochemistry and Molecular Biology (1), Experimental Therapeutics (2), Lymphoma (2), Melanoma Medical Oncology (3), Stem Cell Transplantation (1), Systems Biology (1), Urology (1), and Pediatrics (1)...
  18. The Role of Oxidative Stress in Systemic Amyloidosis
    Steven R Zeldenrust; Fiscal Year: 2010
    ..The principal investigator has completed his clinical training in Internal Medicine and Hematology/Medical Oncology at the Mayo Clinic College of Medicine and now seeks to bring his skills and expertise to bear on the role of ..
  19. Human Breast Cancer Stem Cell Surrogates
    Wendy A Woodward; Fiscal Year: 2012
    ..work represents an established multidisciplinary collaboration between Massimo Cristofanilli, MD Breast Medical Oncology, James Reuben, PhD, Hematopathology, and Wendy Woodward, MD-PhD, Clinical and Experimental Breast Radiation ..
  20. Eastern Cooperative Oncology Group (Main Institution)
    JOHN MUNN KIRKWOOD; Fiscal Year: 2013
    ..1993, and to the Hillman Cancer Center - UPMC Shadyside Medical Center in 2003, with full service inpatient Medical Oncology, Surgical Oncology, and Hematology/BMT as well as a satellite Clinical Translational Science Institute (CTSI) ..
  21. Designer antigen receptors to re-direct T cells to the NY-ESO-1 tumor antigen
    MARCELA VALDERRAMA MAUS; Fiscal Year: 2013
    ..for this NCI Career Development Award is Marcela Valderrama Maus, MD, PhD, who is currently a hematology and medical oncology fellow at Memorial Sloan-Kettering Cancer Center (MSKCC). Dr...
  22. Emory-GA Tech Nanotechnology Center for Personalized an*
    Shuming Nie; Fiscal Year: 2009
    ..cancer biomarkers that can predict clinical outcomes and susceptibility to signal transduction inhibitors in medical oncology (Simons/O'Regan)...
  23. Novel systemic therapy to improve clinical outcome in small cell lung cancer
    Taofeek K Owonikoko; Fiscal Year: 2013
    DESCRIPTION (provided by applicant): This candidate is an Assistant Professor in Hematology and Medical Oncology at Emory University...
  24. Oregon Multidisciplinary Training Program in Emergency Medicine Clinical Research
    Craig D Newgard; Fiscal Year: 2013
    ..of Medicine Divisions of Cardiovascular Medicine, Pulmonary &Critical Care Medicine, and Hematology &Medical Oncology;the Department of Surgery Division of Trauma, Critical Care, &Acute Care Surgery;the Department of ..
  25. CAREER DEVELOPMENT IN PEDIATRIC AND MEDICAL ONCOLOGY
    Irwin D Bernstein; Fiscal Year: 2013
    We are requesting funds for a research career development program in Pediatric and Medical Oncology at the Fred Hutchinson Cancer Research Center and the University of Washington...
  26. Contrast-Enhanced and Image-Guided Surgery of Lung Cancer
    Sunil Singhal; Fiscal Year: 2013
    ..in nanotechnology, instrumentation, software engineering, radiology, pathology, lung/thoracic surgery, and medical oncology. The proposed work will optimize two distinct types of near-infrared contrast agents and will further ..
  27. Endocrine resistance in breast cancer
    ROBERT R CLARKE; Fiscal Year: 2013
    ..and performed by a multidisciplinary team of investigators with expertise in cellular/molecular biology, medical oncology, biostatistics, bioinformatics, and computer engineering...
  28. Antigen Discovery and Development of Tumor-Specific Lymphoma Immunotherapy
    Sattva S Neelapu; Fiscal Year: 2010
    ..is a physician scientist with laboratory training in cancer immunotherapy and clinical training in lymphoma medical oncology. This award would allow him to focus 75% of his effort to career development and the proposed research...
  29. NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo
    Shudong Jiang; Fiscal Year: 2010
    ..A group of investigators which includes clinical specialists in diagnostic radiology, surgical oncology, medical oncology, surgical pathology and medical engineering has been configured to develop and evaluate technology for breast ..
  30. Translational Training Grant in Experimental Therapeutics
    John C Byrd; Fiscal Year: 2012
    ..atmosphere for the training of basic translational scientists and clinical translational scientists in medical oncology and surgical oncology...
  31. The Development of Novel Individualized Therapy for Triple-Negative Breast Cancer
    Jennifer R Diamond; Fiscal Year: 2013
    ..Dr. Diamond is an Assistant Professor of Medicine in the Division of Medical Oncology at the University of Colorado Denver (CU), where she serves as a bridge between the Breast Oncology and ..
  32. TRAINING PROGRAM IN MOLECULAR HEMATOLOGY
    GROVER CARLTON BAGBY; Fiscal Year: 2012
    ..The program is administered through the Divisions of Hematology and Medical Oncology and Molecular Medicine, which constitute the major laboratory research areas of the Department of Internal ..
  33. Training Hematology and Oncology Fellows in Clinical Research
    MIGUEL ANGEL VILLALONA; Fiscal Year: 2013
    ..of this training program is to prepare Hematology and Oncology fellows in the OSU Divisions of Hematology and Medical Oncology for academic careers in clinical and translational cancer investigation...
  34. Synthesis of MUC1 glycopeptides and generation of antibodies for the indentificat
    Katja Michael; Fiscal Year: 2011
    ..D., Ph.D., Department of Melanoma and Medical Oncology;Department of Immunology, University of Texas MD Anderson Cancer Center in Houston, TX...
  35. TRAINING PROGRAM IN INVESTIGATIVE HEMATOLOGY
    Linda M Boxer; Fiscal Year: 2010
    ..These include faculty in biochemistry, molecular pharmacology, microbiology, immunology, pathology, medical oncology, bone marrow transplantation, cardiology, pediatrics, epidemiology, outcome research, and health policy...
  36. Genetic Epidemiology of Young-Onset Pancreatic Cancer
    Robert R McWilliams; Fiscal Year: 2010
    ..The principal investigator, Dr. Robert McWilliams, has clinical training in medical oncology, and post-doctoral training in the genetic epidemiology of cancer...
  37. An Integrated Approach to the Validation of Novel Gastric Cancer Oncogenes
    Lincoln D Nadauld; Fiscal Year: 2013
    ..My goal remains to obtain an appointment in a Division of Medical Oncology as a tenure-track academic physician scientist who pursues innovative research capable of bringing novel ..
  38. TRAINING OF ACADEMIC HEAD AND NECK SURGICAL ONCOLOGIST
    JEFFREY NICHOLAS MYERS; Fiscal Year: 2010
    ..months of advanced head and neck surgical oncology training in which the trainees have extensive exposure to medical oncology, radiation oncology, speech pathology, and dental oncology...
  39. The role of Hedgehog/Gli in normal hematopoiesis and leukemia
    Akil Merchant; Fiscal Year: 2013
    ..Dr. Merchant studied normal hematopoiesis while a resident in internal medicine. As a medical oncology fellow in the laboratory of Dr...
  40. Training Program in Nervous System Tumors
    Tracy T Batchelor; Fiscal Year: 2013
    ..our unique grant focused on nervous system tumors and other training grants at Harvard focused on adult medical oncology. Candidates include physicians completing clinical training in adult and pediatric neuro-oncology, adult and ..
  41. RADIATION THERAPY ONCOLOGY GROUP
    WALTER JOHN CURRAN; Fiscal Year: 2013
    ..Outcomes Committees as well as the newly relocated Biospecimen Resource and from the four core committees of Medical Oncology, Medical Physics, Pathology, and Surgical Oncology...
  42. Penn Center for Innovation in Personalized Breast Screening
    Mitchell D Schnall; Fiscal Year: 2013
    ..primary care, communication, computer science, biostatistics, health services research, bioinformatics, medical oncology, and cancer genetics) as well as the commitment of the clinical leadership (including the Center Principal ..
  43. Enhancing T-Cell Responses with the Glutathione Mimetic NOV-002 in Breast Cancer
    ALBERTO JOSE MONTERO; Fiscal Year: 2013
    ..His clinical mentor Dr. Mark Pegram has been at the forefront of clinical research in breast medical oncology and has been involved with the development of novel targeted therapies for the treatment of HER-2 positive ..
  44. EASTERN COOPERATIVE ONCOLOGY GROUP
    Joseph Sparano; Fiscal Year: 2013
    ..was recently awarded a K12 Calabresi grant which will support the recruitment of additional junior medical oncology faculty members engaged in clinical research...
  45. ONCOLOGY RESEARCH TRAINING GRANT
    Kathleen A Cooney; Fiscal Year: 2013
    ..3 years of house officer training in Internal Medicine and a year of clinical subspecialty training in medical oncology/hematology...
  46. Cancer Genetics Career Development Program
    Jeffrey N Weitzel; Fiscal Year: 2010
    ..and a compelling program announcement posted at national meetings and disseminated to directors of 145 medical oncology and 60 genetics programs...
  47. Role of Ron kinase in pancreatic cancer
    James W Freeman; Fiscal Year: 2013
    ..impact that this award will have on veterans health care is that this research project is integrated with the medical oncology fellowship program and therefore offers an excellent training venue for candidates seeking to become ..
  48. Targeting HPV E6-Dependent Hypoxia-Induced NF-kappa B in Cervical Cancer
    Matthew B Rettig; Fiscal Year: 2013
    ..We have assembled a team of physician-scientists with diverse skill sets from various disciplines, including medical oncology, gynecologic oncology, and gynecologic pathology to further our molecular understanding of the hypoxic ..
  49. ACADEMIC TRAINING IN MEDICAL ONCOLOGY
    Antoni Ribas; Fiscal Year: 2013
    ..This task has become increasingly critical as the discipline of medical oncology translates basic science principles into clinical practice...
  50. Selective Inhibition of HDAC6 in Cancer Therapy
    James E Bradner; Fiscal Year: 2012
    ..The candidate is a physician-scientist with clinical training in medical oncology and hematology...
  51. Exploring the creation of nurses'informal documentation and use in clinical work
    JACQUELYN WILLIAMSON BLAZ; Fiscal Year: 2013
    ..of this dissertation research is to develop a deep understanding of nurses'brains in the context of a medical oncology unit...
  52. TRAINING PROGRAM IN CANCER BIOLOGY
    Kenneth K Tanabe; Fiscal Year: 2013
    ..derived primarily from the Massachusetts General Hospital (MGH) clinical residency and fellowship programs in medical oncology, radiation oncology, and surgery. The quality of these candidates is outstanding...
  53. Intervention to Increase Chemotherapy Tolerance in Elderly Cancer Patients
    Lara Traeger; Fiscal Year: 2012
    ..with stage II/III elderly colon cancer patients receiving chemotherapy (n=20), and review findings with MGH medical oncology staff for additional feedback...
  54. Genome Discovery and Validation in Upper Gastrointestinal Carcinomas
    ADAM JOEL BASS; Fiscal Year: 2012
    As a physician trained in medical oncology, I aim to develop the skills necessary to allow me to become an independent translational physician-scientist...
  55. ACADEMIC TRAINING IN HEMATOLOGY
    VICTOR JACK MARDER; Fiscal Year: 2013
    ..This award was initiated in July, 2002, and supports 4 fellowship slots in years 2 and 3 of Hematology/Medical Oncology training. The Program Director is Victor Marder, MD, and the Associate Program Director is Donald Kohn, MD...
  56. Translational Physician-Scientist Training Program in Oncology
    Dong M Shin; Fiscal Year: 2013
    DESCRIPTION (provided by applicant): The Department of Hematology and Medical Oncology (HMO) and the Winship Cancer Institute at Emory University proposes a T32 Translational Physician-Scientist Training Program in Oncology. This 2...
  57. Sanford Community Cancer Consortium
    Miroslaw Mazurczak; Fiscal Year: 2013
    ..The Sanford component has two affiliate sites - Avera Cancer Institute (Avera Medical Oncology/Hematology and Avera Hematology and Transplant) Sioux Falls, SD and Front Range Cancer Specialists in Fort ..
  58. In Vivo Cellular and Molecular Imaging Center@Stanford
    Sanjiv S Gambhir; Fiscal Year: 2013
    ..The ICMIC@Stanford investigators are from a variety of disciplines and expertise including Medical Oncology, Radiochemistry, Chemistry, Radiology, Microbiology &Immunology, Medical Physics, Bioengineering, ..
  59. U10 Full Member Application Affiliated with SWOG
    Cathy Eng; Fiscal Year: 2013
    ..provides comprehensive services to cancer patients through 13 interdisciplinary care centers, integrating medical oncology, surgery, radiation oncology, nursing, pharmacology, and other care providers by disease site/type...
  60. Southwest Oncology Group Treatment Grant
    Charles D Blanke; Fiscal Year: 2013
    ..There are three new initiatives in this application. Two new adult medical oncology intergroup proposals, one dealing with advanced gynecologic cancer, the U.S...
  61. An Intervention to Improve Outcomes in Patients with Advanced Cancer
    Ruth McCorkle; Fiscal Year: 2011
    ..Implementation, Maintenance) to evaluate clinical outcomes and the sustainability of the intervention in medical oncology. The specific aims are to: 1) Integrate discharge planning into an intervention provided by an oncology APN ..
  62. Florida Hospital Cancer Institute Community Clinical Oncology Program
    LEE ZEHNGEBOT; Fiscal Year: 2013
    ..Florida Hospital South (FH) offers a full array of services including medical oncology, radiation oncology, pediatric oncology, bone marrow transplantation, surgical oncology, neuro-oncology, and ..
  63. Research Training Program in Molecular and Cellular Hematology
    Margaret H Baron; Fiscal Year: 2013
    ..Along with the enormous growth in the research portfolio of the Division of Hematology and Medical Oncology and the recruitment of new faculty over the past decade, we are now in a very strong position to provide an ..
  64. PREDOCTORAL FELLOWSHIPS FOR STUDENTS WITH DISABILITIES
    ERIKA LAWSON; Fiscal Year: 2007
    ..edu 11c. DEPARTMENT, SERVICE, LABORATORY, OR EQUIVALENT Medicine 11d. MAJOR SUBDIVISION Medical Oncology 13. NAME AND TELEPHONE NO. OF ADVISOR IF DIFFERENT FROM 11a...
  65. HYPERTHERMIA AND PERFUSION EFFECTS IN CANCER THERAPY
    Mark Dewhirst; Fiscal Year: 2009
    ..A multidisciplinary approach includes experts in radiation and medical oncology, biostatistics, radiology, pathology, surgery, cancer biology, physiology, genetics, hyperthermia physics and ..
  66. PAR04-122, Extramural Research Facilities Improvement P*
    Michael R Grever; Fiscal Year: 2010
    ..focus of the recruitments will include: a Director of Gastrointestinal Malignancy;a Director of Head and Neck Medical Oncology;a senior physician scientist with expertise in multiple myeloma;three junior faculty investigators in solid ..
  67. Identifying New Aging and Longevity Genes in Caenorhabditis elegans
    Muneesh Tewari; Fiscal Year: 2007
    ..training, including internship and residency in Internal Medicine and subspecialty clinical training in Medical Oncology. He has developed an interest in aging and longevity and wishes to pursue a program of career development ..
  68. Optimizing Nonmyeloablative Stem Cell Transplantation
    Marco Mielcarek; Fiscal Year: 2007
    DESCRIPTION (provided by applicant): As a Medical Oncology fellow at the Fred Hutchinson Cancer Research Center I have been impressed by the toxicities associated with conditioning regimens used for conventional hematopoietic stem cell ..
  69. Pain, Opioids, and Sleep in Cancer Patients
    Kathy Parker; Fiscal Year: 2006
    unreadable] DESCRIPTION: (provided by applicant) Medical oncology patients experiencing pain frequently report nocturnal sleep disturbances and daytime sleepiness that adversely affect their functional health status (FHS) and quality of ..
  70. PPARgamma: Biomarker for Breast Cancer in Older Women
    Pearl Seo; Fiscal Year: 2009
    ..Her work towards this goal included training in Geriatrics and Medical Oncology and a Masters of Public Health degree...
  71. Cytokine Inhibition in Hepatocellular Carcinoma
    Jonathan Schwartz; Fiscal Year: 2005
    The candidate is a Clinical Assistant Professor in the divisions of Medical Oncology and Hematology in the Department of Medicine at The Mount Sinai School of Medicine. He is also Co-Director of the Hematology-Oncology Fellowship...
  72. Combined Cytokine-Monoclonal Antibody Therapy in Lymphoma
    Pierluigi Porcu; Fiscal Year: 2007
    ..State University (OSU) with extensive training in basic cancer laboratory research, cytokine biology, and medical oncology, with a strong concentration in lymphoma...
  73. CANCER AND LEUKEMIA GROUP B
    William Sikov; Fiscal Year: 2002
    ..At present, our CALGB network includes 50 investigators, 3 hospitals, 2 hospital-based medical oncology practices, 8 community-based medical oncology private practices at 12 private practice offices and 2 ..